Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-25-021373
Filing Date
2025-03-06
Accepted
2025-03-06 16:14:46
Documents
4
Effectiveness Date
2025-03-06

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm258269d1_s8.htm S-8 47411
2 EXHIBIT 5.1 tm258269d1_ex5-1.htm EX-5.1 6296
3 EXHIBIT 23.1 tm258269d1_ex23-1.htm EX-23.1 1683
4 EX-FILING FEES tm258269d1_ex-filingfees.htm EX-FILING FEES 15767
  Complete submission text file 0001104659-25-021373.txt   72316
Mailing Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE MAIN STREET, 14TH FLOOR CAMBRIDGE MA 02142 617-417-5868
Black Diamond Therapeutics, Inc. (Filer) CIK: 0001701541 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-285596 | Film No.: 25715407
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)